Malignant ovarian germ cell tumors: analysis of 32 cases

F Yilmaz1, T Gül, A K Uzunlar

  • 1Department of Pathology, Obstetrics and Gynecology, Medical Faculty of Dicle University, Diyarbakir, Turkey.

Abstract

Insights

Malignant ovarian germ cell tumors (MOGCT) management is safe with fertility preservation. Dysgerminoma showed a better prognosis compared to non-dysgerminomatous MOGCT, impacting patient outcomes.

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Reproductive Medicine

Background:

  • Malignant ovarian germ cell tumors (MOGCT) are rare but aggressive neoplasms.
  • Understanding clinicopathologic characteristics is crucial for effective management and prognosis.

Purpose of the Study:

  • To evaluate clinicopathologic features and outcomes of MOGCT patients.
  • To assess the safety of fertility-sparing management in MOGCT.

Main Methods:

  • Retrospective review of clinical charts and pathology reports.
  • Analysis of 32 MOGCT patients treated between 1983 and 1999.
  • Evaluation of tumor histology, site, and treatment modalities (surgery and chemotherapy).

Main Results:

  • Dysgerminoma was the most common type (40.6%), followed by immature teratoma (28.1%).
  • Unilateral involvement was predominant (93.8%).
  • A correlation between pathologic findings and clinical outcome was observed, suggesting histology impacts prognosis.

Conclusions:

  • Dysgerminoma demonstrated a significantly better prognosis than non-dysgerminomatous MOGCT.
  • Fertility preservation in MOGCT management is confirmed as a safe approach.

Related Concept Videos